Abstract:For patients with gastrointestinal stromal tumors (GISTs) and liver metastases, there is still debate about whether radiofrequency ablation (RFA) or hepatectomy is preferable. The present study aimed to compare the clinical outcomes of RFA with hepatectomy in patients with GISTs and liver metastases. The present retrospective study consisted of a cohort of 43 patients who had been diagnosed with liver metastases from GISTs between January 2010 and December 2022. The study included 18 patients who received RFA combined with tyrosine kinase inhibitor (TKI) therapy (RFA group) and 25 patients who underwent hepatectomy combined with TKI therapy (hepatectomy group). For the patients with liver metastases, the progression‐free survival (PFS) rates at 1, 3 and 5 years were 66.5, 38.2 and 33.9%, respectively. Notably, patients in the hepatectomy group exhibited significantly improved PFS times compared with those in the RFA group (median PFS, 42.7 months vs. 14.3 months; P=0.034). Furthermore, the time to imatinib treatment failure (TTF) was notably improved in the hepatectomy group compared with that in the RFA group, and this difference was statistically significant (median TTF, 71.1 vs. 38.0 months; P=0.041). However, the overall survival (OS) times of patients who received RFA and those who had hepatectomy did not differ significantly (median OS, not reached vs. not reached, P=0.120). There was no statistically significant distinction in PFS and TTF between patients who underwent hepatectomy combined with postoperative TKI and those who underwent hepatectomy combined with perioperative TKI (median PFS, 29.5 vs. not reached; P=0.520; median TTF, 66.4 months vs. 71.1 months; P=0.430). The univariate and multivariate analyses consistently identified the sole prognostic factor affecting PFS as hepatectomy combined with TKI therapy (hazard ratio, 0.379; 95% CI, 0.159‐0.899; P=0.028). In conclusion, hepatectomy combined with TKI therapy improved prognosis for patients with liver metastases to a greater extent than RFA combined with TKI therapy. For this type of patient, hepatectomy may be a preferable option.

Management of liver metastases of gastrointestinal stromal tumor]

Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).

Percutaneous microwave ablation liver partition and portal vein embolization for planned hepatectomy due to large gastrointestinal stromal tumor metastases: A case report.

Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Followed by Sunitinib Compared to Followed by Imatinib-a Multi-Center Cohort Study

Role of Surgery in the Management of Liver Metastases from Gastrointestinal Stromal Tumors

Dianosis and Treatment of Hepatic Metastasis from Gastrointestinal Stromal Tumor

Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors

Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report

[Management of gastrointestinal stromal tumors]

[Strategies in Diagnosis and Management for Advanced or Metastatic Gastrointestinal Stromal Tumor].

Management strategies for advanced gastrointestinal stromal tumors after failure of imatinib

Status of surgical treatment in recurrent and metastatic gastrointestinal stromal tumors

Primary Gastrointestinal Stromal Tumor of the Liver: A Case Report and Review of the Literature

The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study

Radiofrequency ablation vs. hepatectomy for liver metastases from gastrointestinal stromal tumors

Analysis of the Clinical and Pathological Characteristics of 26 Cases of Gastrointestinal Stromal Tumors with Hepatic Metastasis

Treatment Strategies for Recurrent or Metastatic Gastrointestinal Stromal Tumor

[Treatment of Recurrent or Metastatic Gastrointestinal Stromal Tumor: Surgery or Not].

Role of surgery in treatment of recurrent or metastatic gastrointestinal stromal tumor

The management of metastatic GIST: current standard and investigational therapeutics

The Diagnosis and Treatment of Gastrointestinal Stromal Tumors with Hepatic Metastases